Impact of Physical Exercise on Levodopa Therapy Across Parkinson’s Disease Stages
Journal of Parkinson’s Disease · 2024
DOI: 10.3233/jpd-230384 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Parkinson’s Disease, 2024. Verfasst von Monika Figura und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland. Hauptthemen laut MEDLINE: Levodopa, Parkinson Disease, Antiparkinson Agents, Exercise. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Levodopa is the gold standard of treatment in Parkinson’s disease (PD). Its clinical effect changes as the disease progresses. Wearing off is a frequent first manifestation of motor fluctuations. Some patients with advanced PD report faster wearing off after physical exercise.
Objective
The aim was to assess if pharmacokinetics of levodopa is influenced by physical exercise in patients with different disease advancement.
Methods
22 patients with PD (12 untreated with levodopa and 10 with motor fluctuations) and 7 healthy controls (HC) were included. Plasma samples were collected at 9 fixed timepoints following administration of levodopa/benserazide 200/50 mg for two days: rest day and standardized physical exercise day. Clinical assessment with Unified Parkinson Disease Rating Scale part III (UPDRS III) was performed in fixed timepoints. Liquid chromatography-tandem mass spectrometry was used to measure levodopa concentrations.
Results
No differences between the HC, levodopa naïve and advanced PD groups were observed regarding selected pharmacokinetic parameters. In advanced PD and HC no differences in pharmacokinetic parameters of levodopa with and without effort were observed. In levodopa naïve PD group higher mean residence time after rest than after exercise (168.9±48.3 min vs. 145.5±50.8 min; p = 0.026) was observed. In advanced PD group higher UPDRS III score (14.45±5.5 versus 20.9±6.1 points, p = 0.04) was observed after exercise.
Conclusions
The deterioration of motor status of advanced PD patients after physical effort is not reflected by changes in pharmacokinetics but rather mediated by central mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland.
- Department of Drug Chemistry, Pharmaceutical and Biomedical Analysis, Faculty of Pharmacy, Medical University of Warsaw, Poland.
- Student Scientific Group NEKON, Department of Neurology, Faculty of Health Sciences, Medical University of Warsaw, Poland.
Zitieren
APA
Figura, M., Mrozowicz, A., Milanowski, Ł., Szlufik, S., Raćkowska, E., Lypkan, H., Friedman, A., Koziorowski, D., & Giebułtowicz, J. (2024). Impact of Physical Exercise on Levodopa Therapy Across Parkinson’s Disease Stages. Journal of Parkinson’s Disease. https://doi.org/10.3233/jpd-230384
Vancouver
Figura M, Mrozowicz A, Milanowski Ł, Szlufik S, Raćkowska E, Lypkan H, et al. Impact of Physical Exercise on Levodopa Therapy Across Parkinson’s Disease Stages. Journal of Parkinson’s Disease. 2024. doi:10.3233/jpd-230384
BibTeX
@article{Figura2024,
author = {Figura, Monika and Mrozowicz, Agnieszka and Milanowski, Łukasz and Szlufik, Stanisław and Raćkowska, Emilia and Lypkan, Hanna and Friedman, Andrzej and Koziorowski, Dariusz and Giebułtowicz, Joanna},
title = {Impact of Physical Exercise on Levodopa Therapy Across Parkinson’s Disease Stages},
journal = {Journal of Parkinson’s Disease},
year = {2024},
doi = {10.3233/jpd-230384}
}
EUVIMED